MedPath

Amphonex

Brand Name: Amphonex

Generic Name: Amphotericin B

Active
Registration Number

DR-XY47267

Dosage Form

Lyophilized Powder for Intravenous Infusion

Issuance Date

November 4, 2021

Expiry Date

May 11, 2026

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength50mg
Packaging20 mL USP Type 1 clear colorless tubular vial with 20 mm chlorobutyl slotted rubber bung and 20 mm royal blue aluminum flip off seal with 5 micron syringe filter (Box of l's)

Classification

C
Classification
Prescription Drug (RX)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Amphotericin BActive
Monograph: Amphotericin B

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform